Blake Insomnia Therapeutics, Inc. (OTC:BKIT) Announces Change in Business Strategy and name change submission to BioHemp International to Focus on a Rollup Strategy in the CBD Market

World News: . []

NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics, Inc  (OTC: BKIT, “The Company”) announces that it is rebranding and changing its business model to take advantage of the huge opportunity in the burgeoning cannabidiol (CBD) sector by rolling up and consolidating the growing number of CBD providers under one platform to become the leading source and distributor of CBD in the marketplace. Reflecting this transition, the Company has submitted a name change request to rebrand as BioHemp International (), complementing its new role in this expanding industry.    

The Company is positioning itself to be the market front-runner for distribution in the growing CBD industry. According to Brightfield Research, the CBD market is expected to reach . Currently, there are no dominant distributors in the CBD market as the nascent industry has been dominated by "mom & pop" sellers who have been in the industry since its infancy, and lack the sophistication that would be prevalent in a mature industry. The number of entrants is only expected to rise with the rapid expansion of the sector, but an inflection point is about to occur. According to Harvard Business School, the first stage of industry consolidation begins when the combined market share of the three largest companies drops between 30% and 10%. The CBD market is at the precipice of consolidation, and the Company is positioned to accomplish this and become the market leader.

With a strategy to roll up mono and multi-branded e-commerce and brick & mortar retailers under one platform, the Company is focusing on acquiring strong CBD assets that will make the Company the market force in consolidation across the CBD industry. By creating economies of scale for brands and vendors, the Company is positioning itself to be the CBD distribution market leader, and capitalize off the beginning of a seismic shift in this fast growing industry.

Following the approval of name submission and change in business direction, the market ticker will remain the same under BKIT.

For more information please visit:

More news and information about Blake Insomnia Therapeutics, Inc.

Published By:

Globe Newswire: 13:00 GMT Wednesday 15th May 2019

Published: .

Search for other references to "blake" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us